查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532927

人类增强市场：2024-2029 年预测

Human Augmentation Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

人类增强市场预计将以 20.44% 的复合年增长率成长，从 2024 年的 2,666.21 亿美元增至 2029 年的 6,757.67 亿美元。

人类增强技术专注于创造分析和身体改善。这是一个技术主导的过程，旨在提高人类生产力和绩效。如果以正确的方式进行扩张，就有可能改善您的整体生活品质。恢復人类能力的“人类能力复製”，例如残障人士的助听器；提高执行任务能力的“人类能力复製”，例如用于改善身体素质的人工方法；三种类型：“补充人类能力”，最后是“超人能力”，它们帮助我们做一些我们单独无法完成的事情，例如飞行的能力。

其中包括增强体力的义肢和外骨骼；增强身体功能或替代受损器官的心律调节器、人工电子耳和胰岛素帮浦等植入；以及能够实现大脑与脑机等外部设备之间直接通讯的植入物。

介绍

人类增强市场主要是由世界各地医疗保健系统的改善和人们对健康生活方式的认识不断提高所推动的。 GDP 和可支配收入的成长也使人们能够在健康相关问题上花费更多。此外，综合医学方法在北美和欧洲国家广泛使用和接受。世界各地正在快速进步，以改善不同医疗机构和相关人员之间的合作。

医疗保健基础设施持续成长。许多国家的医学研究支出正在增加。美国在这​​一领域仍处于领先地位。由于健康指标的改善和医疗基础设施的改善，人类增强市场预计将成长。

全球智慧型手机用户数量正在迅速增加。北美地区的智慧型手机普及率最高。该地区在网路基础设施和宽频部署方面投入了大量资金。

人口成长的主要驱动力是育龄人口数量的增加、出生率的显着变化以及医疗保健设施的增加。光是亚洲就拥有世界人口的五分之三。非洲大陆由人口最多的两个国家中国和印度组成，两国人口合计占世界人口的五分之二。此外，到2022年，据报道，印度智慧型手机用户数量在过去8年里从1.5亿增加到7.5亿。

市场驱动因素：

  • 预计全球技术进步的成长将推动市场：

人工智慧和人工智慧、生物技术、奈米技术、机器人技术和材料科学等领域的快速发展正在推动更复杂、更有效的增强智慧解决方案的开发。医疗保健技术的进步也是市场成长的关键因素。例如，矫正器具、植入和医疗设备等技术是这些进步的一部分，随着医疗保健需求的发展，它们被用于改善患者预后、增加活动能力和恢復丧失的功能。因此，人类增强市场预计在预测期内将会成长。

  • 人口老化的加剧和对提高性能的需求预计将推动人类增强市场

世界人口的显着增加包括患有多种与老年相关的疾病的老年人。因此，与老龄化相关的残疾和健康状况的盛行率正在增加，人类增强技术提供了解决与老龄化相关的挑战（例如行动障碍、感觉障碍和认知能力下降）的解决方案，并可以改善人们的生活品质。

此外，外骨骼、穿戴式装置和认知增强器等技术越来越多地用于提高体力、耐力、认知能力和情境察觉，并用于体育、国防、工业等领域的各种应用。人类在不同领域表现的技术的需求不断增长。

市场限制因素：

除了好处之外，人类增强也为製造它的公司带来了一些挑战，包括与使用侵入性手术、植入式设备、增强药物和生物技术相关的风险。

人们也担心可能会加剧社会不平等，以及个人范围的扩大可能会引发有关同意、隐私、公平和公平等复杂的道德和社会问题，这可能会在个人和非扩大范围之间造成差距。因此，这些因素可能会阻碍预测期内的市场成长。

预计北美地区的成长最为明显

按地区划分，北美预计主导市场。该地区对生长产品的需求正在增加。此外，该地区正在不断创新由科技驱动的医疗穿戴产品。北美最大的人类增强市场是美国。北美地区的智慧型手机普及率也最高，预计将提振市场。

美国是北美地区，拥有Google等主要参与者，为该地区的市场成长做出了积极贡献。因此，由于人们对健康的意识不断增强，加上医疗设施的改善和智慧型手机用户数量的增加，北美地区的人类增强市场预计在预测期内将显着增长。

主要企业提供的产品

B-Temia 提供 Keeogo。 Keeogo 是一款智慧动力矫正器具，可以帮助患有神经系统疾病的人安全、自由地行走。

Ekso Bionics：这种机器人外骨骼是一种支持脊髓损伤患者康復并让他们恢復体力的设备。

主要进展：

  • 2023年9月，Neuralink宣布将开始招募PRIME（精密机器人植入脑机介面）的临床试验。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章人类增强市场：副产品

  • 介绍
  • 眼镜产品
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 领带
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 手腕佩戴
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 鞋类
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 身体穿着
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力

第六章人类增强市场：依最终用户分类

  • 介绍
  • 卫生保健
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 製造业
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 航太/国防
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力

第七章人类增强市场：按地区

  • 介绍
  • 北美洲
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 副产品
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 副产品
    • 按最终用户
    • 按国家/地区

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章 公司简介

  • B-temia
  • Ekaso Bionics
  • Magic Leap Inc.
  • Lifeward
  • Vuzix Corporations
  • Samsung Electronics
  • Raytheon Technologies Corporation
  • Google Inc.
  • BrainGate Inc.
简介目录
Product Code: KSI061610261

The human augmentation market is projected to grow at a CAGR of 20.44% to reach US$675.767 billion by 2029 from US$266.621 billion in 2024.

Human augmentation technology focuses on creating analytic and physical improvements. It's a technology-driven process that aims to increase human productivity and capability. If done in the right manner, augmentation has the potential to improve one's overall quality of life. It can be divided into three types: replicating human ability which can restore human ability like a hearing aid for the deaf, there is supplementing human ability which can improve the ability to perform the work, for instance, artificial methods used to increase strength, and at last exceeding human ability that helps to do things that can't be done alone like the ability to fly.

This includes technologies like artificial limbs and exoskeletons that can enhance physical strength, implants such as pacemakers, cochlear implants, and insulin pumps that enhance bodily functions or replace damaged organs, Brain-Computer Interfaces or BCIs that allow direct communication between the brain and external devices, and genetic engineering that allows to modifying genes to enhance desired traits or mitigate genetic diseases.

INTRODUCTION:

The human augmentation market is driven majorly by improving healthcare systems across the globe and growing awareness among people for a healthy lifestyle. The growth in GDP and disposable income is also a contributing factor as people can spend on their health-related issues. Also, the efforts of integrated care have been widely used and accepted in North American and European countries. There is rapid progress taking place across the globe to improve the coordination among the various healthcare settings and stakeholders.

The healthcare infrastructure is improving continuously across the growth. Many countries are increasingly spending on medical research. The United States remains the leading country in this section. With the improving health indices and better healthcare infrastructure, the human augmentation market is expected to witness growth.

The number of smartphone users across the globe is increasing rapidly. North America has the highest penetration of smartphones. This region is investing heavily in network infrastructure and the adoption of broadband.

The population growth is mainly driven by the increasing number of people surviving to the reproductive age, significant changes in the fertility rates, and better healthcare facilities available. Asia constitutes three-fifths of the world's population alone. The continent consists of the two most populated countries- China and India, which together constitute two-fifths of the world's population. Furthermore, in 2022 it was reported that in the last 8 years, the number of smartphone users in India went from 150 million to 750 million.

MARKET DRIVERS:

  • Growth in technological advancements globally is predicted to propel the market:

The rapid advancements in fields such as artificial intelligence or AI, biotechnology, nanotechnology, robotics, and materials science are enabling the development of more sophisticated and effective augmentation solutions. The advancements in healthcare technology are also a significant part of market growth. For instance, technologies like prosthetics, implants, and medical devices are part of these advancements and as healthcare needs evolve, there is a growing demand for advanced solutions to improve patient outcomes, enhance mobility, and restore lost functionalities. Therefore, the human augmentation market is anticipated to grow over the forecast period.

  • The growing aging population and demand for enhanced performance are projected to drive the human augmentation market.

There is a significant increase in the global population which also includes the aging people who have several medical conditions due to old age. This is leading to a higher prevalence of age-related disabilities and health conditions and solutions to address age-related challenges, such as mobility impairments, sensory deficits, and cognitive decline, thereby improving the quality of life for the elderly population can be offered by human augmentation technology.

Also, technologies such as exoskeletons, wearable devices, and cognitive enhancers are increasingly used to improve physical strength, endurance, cognitive abilities, and situational awareness to meet the growing demand for technologies that can enhance human performance in various sectors, including sports, defense, and industry.

MARKET RESTRAINT:

Human augmentation with its benefits also provides some challenges to the companies that manufacture them such as risks associated with invasive procedures, implantable devices, and the use of pharmaceuticals or biotechnologies for enhancement purposes and ensuring the safety and efficacy of human augmentation technologies is paramount which can be challenging for them.

Also, there are some concerns about the potential for exacerbating social inequalities, creating divides between augmented and non-augmented individuals which can raise complex ethical and social questions regarding issues such as consent, privacy, equity, and fairness, and the cost barriers could limit adoption and exacerbate disparities in access to augmentation benefits as human augmentation technologies are expensive and may not be accessible to all individuals. Therefore, these factors might hinder the market growth over the forecast period.

Growth is projected to be prominent in the North American region.

In terms of geography, North America is expected to dominate the market. The region is facing an increasing demand for augmentation products. Moreover, the region is continuously innovating technologically driven medical wearable products. The US represents the largest market for human augmentation in North America. Also, North America constitutes the highest penetration of smartphones which is anticipated to boost the market.

The presence of key players like Google in the USA which is in the North American region is contributing positively to the market growth in the region. Therefore, the awareness among people for health awareness coupled with improving healthcare facilities and increasing smartphone users are anticipated to fuel the North American region human augmentation market significantly over the forecast period.

Products Offered by Key Companies:

B-Temia: The company offers Keeogo which is a smart powered Knee Orthosis that can help people living with neurological conditions to walk safely and freely.

Ekso Bionics: The robotic exoskeleton is a device that can support patients living or recovering from spinal cord injuries and allow them to work on regaining strength back.

Key Developments:

  • In September 2023, Neuralink announced they are open for recruitment for the human trials for PRIME or Precise Robotically Implanted Brain-Computer Interface.

Segmentation:

By Product

  • Eye-wear
  • Neck-wear
  • Wrist-wear
  • Foot-wear
  • Body-wear
  • Others

By End-Users

  • Healthcare
  • Manufacturing
  • Aerospace and Defense
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. HUMAN AUGMENTATION MARKET, BY PRODUCT

  • 5.1. Introduction
  • 5.2. Eye-Wear
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Neck-Wear
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Wrist-Wear
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Foot-Wear
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Body-Wear
    • 5.6.1. Market Trends and Opportunities
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness
  • 5.7. Others
    • 5.7.1. Market Trends and Opportunities
    • 5.7.2. Growth Prospects
    • 5.7.3. Geographic Lucrativeness

6. HUMAN AUGMENTATION MARKET, BY END-USERS

  • 6.1. Introduction
  • 6.2. Healthcare
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Manufacturing
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Aerospace and Defense
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Trends and Opportunities
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. HUMAN AUGMENTATION MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Product Type
    • 7.2.2. By End-Users Type
    • 7.2.3. By Country
      • 7.2.3.1. USA
        • 7.2.3.1.1. Market Trends and Opportunities
        • 7.2.3.1.2. Growth Prospects
      • 7.2.3.2. Canada
        • 7.2.3.2.1. Market Trends and Opportunities
        • 7.2.3.2.2. Growth Prospects
      • 7.2.3.3. Mexico
        • 7.2.3.3.1. Market Trends and Opportunities
        • 7.2.3.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. By Product Type
    • 7.3.2. By End-Users Type
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
        • 7.3.3.1.1. Market Trends and Opportunities
        • 7.3.3.1.2. Growth Prospects
      • 7.3.3.2. Argentina
        • 7.3.3.2.1. Market Trends and Opportunities
        • 7.3.3.2.2. Growth Prospects
      • 7.3.3.3. Others
        • 7.3.3.3.1. Market Trends and Opportunities
        • 7.3.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. By Product Type
    • 7.4.2. By End-Users Type
    • 7.4.3. By Country
      • 7.4.3.1. UK
        • 7.4.3.1.1. Market Trends and Opportunities
        • 7.4.3.1.2. Growth Prospects
      • 7.4.3.2. Germany
        • 7.4.3.2.1. Market Trends and Opportunities
        • 7.4.3.2.2. Growth Prospects
      • 7.4.3.3. France
        • 7.4.3.3.1. Market Trends and Opportunities
        • 7.4.3.3.2. Growth Prospects
      • 7.4.3.4. Spain
        • 7.4.3.4.1. Market Trends and Opportunities
        • 7.4.3.4.2. Growth Prospects
      • 7.4.3.5. Others
        • 7.4.3.5.1. Market Trends and Opportunities
        • 7.4.3.5.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. By Product Type
    • 7.5.2. By End-Users Type
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
        • 7.5.3.1.1. Market Trends and Opportunities
        • 7.5.3.1.2. Growth Prospects
      • 7.5.3.2. UAE
        • 7.5.3.2.1. Market Trends and Opportunities
        • 7.5.3.2.2. Growth Prospects
      • 7.5.3.3. Israel
        • 7.5.3.3.1. Market Trends and Opportunities
        • 7.5.3.3.2. Growth Prospects
      • 7.5.3.4. Others
        • 7.5.3.4.1. Market Trends and Opportunities
        • 7.5.3.4.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. By Product Type
    • 7.6.2. By End-Users Type
    • 7.6.3. By Country
      • 7.6.3.1. Japan
        • 7.6.3.1.1. Market Trends and Opportunities
        • 7.6.3.1.2. Growth Prospects
      • 7.6.3.2. China
        • 7.6.3.2.1. Market Trends and Opportunities
        • 7.6.3.2.2. Growth Prospects
      • 7.6.3.3. India
        • 7.6.3.3.1. Market Trends and Opportunities
        • 7.6.3.3.2. Growth Prospects
      • 7.6.3.4. South Korea
        • 7.6.3.4.1. Market Trends and Opportunities
        • 7.6.3.4.2. Growth Prospects
      • 7.6.3.5. Indonesia
        • 7.6.3.5.1. Market Trends and Opportunities
        • 7.6.3.5.2. Growth Prospects
      • 7.6.3.6. Thailand
        • 7.6.3.6.1. Market Trends and Opportunities
        • 7.6.3.6.2. Growth Prospects
      • 7.6.3.7. Taiwan
        • 7.6.3.7.1. Market Trends and Opportunities
        • 7.6.3.7.2. Growth Prospects
      • 7.6.3.8. Others
        • 7.6.3.8.1. Market Trends and Opportunities
        • 7.6.3.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. B-temia
  • 9.2. Ekaso Bionics
  • 9.3. Magic Leap Inc.
  • 9.4. Lifeward
  • 9.5. Vuzix Corporations
  • 9.6. Samsung Electronics
  • 9.7. Raytheon Technologies Corporation
  • 9.8. Google Inc.
  • 9.9. BrainGate Inc.